Search
Close this search box.

 Skin Cancer and SRT – Jeff Goldstein Interview

All transplant patients have a greater chance of developing skin cancer compared to the general population. In fact, research shows that transplant recipients have up to a 100 times higher risk for developing skin cancer compared to the general population. Transplant patients tend to develop a skin cancer called squamous cell carcinoma (SCC) although many […]

WFN1 News – Dermatologist Dr. Ellen Turner on CEO Money

In this week’s CEO Money segment Michael Yorba sits down with Dallas dermatologist, Dr. Ellen Turner to learn about skin cancer, and why her practice is using Superficial Radio Therapy (SRT) — a new, non-surgical skin cancer treatment option that has a remarkable cure rate. Read the full article and listen to the interview here.

Educating Your Patients on Keloid Removal Success Rates

A keloid is a cutaneous mass that characteristically develops following a dermal injury. The keloid has beset dermatologists and cosmetic surgeons for decades, in view of both its pathological evolution and therapeutic challenges. Classically described as an overgrowth of tissue that extends beyond the borders of the original wound, keloids differ from that of hypertrophic […]

Skin Cancer and SRT – Jeff Goldstein Interview

Jeff Goldstein is a double lung transplant recipient and a multiple skin cancer survivor. Transplant recipients are immune compromised and has a pre-disposition to skin cancer. As a Floridian, Jeff spent a lot of time out in the Miami sun without sunscreen. Due to the sun exposure leading to skin cancer, Jeff has undergone over […]

What is Superficial Radio Therapy? (SRT)

What is Superficial Radio Therapy? Superficial Radio Therapy is the latest non-invasive, non-melanoma skin cancer treatment option. Superficial Radio Therapy is administered with the use of the SRT-100™, our state-of-the-art system inspired by the tried-and-true Superficial Radio Therapy systems that were once the proven gold standard among dermatologists and radiation oncologists. The difference? Our machine […]

Dr. David J Goldberg Presents at AAD 2017

Superficial radiation advances as option for NMSC treatment David J. Goldberg, MD, JD, examined the genesis of the evolution of superficial radiation therapy (SRT) during “New and Emerging Therapies for Non-Melanoma Skin Cancers,” part of “New Emerging Therapies” (S022). Dr. Goldberg is a dermatologic surgeon at Skin Laser and Surgery Specialists of New York/New Jersey. […]

Ask Your Doctor About the SRT-100™ to Treat Your Basal Cell Carcinoma

Have you been diagnosed with skin cancer? You are not alone. Skin cancer is one of the most commonly occurring forms of cancer, with more than one in every three new cancers diagnosed as skin cancer. Basal cell carcinoma is one type of skin cancer and occurs more frequently than any other form of skin […]

Treat Your Patients’ Basal Cell Carcinoma with the Revolutionary SRT-100™

Any dermatologist knows just how devastating a skin cancer diagnosis can be to his or her patients. Skin cancer is diagnosed nearly three times as often as any other form of cancer, with the most common of all skin cancers being basal cell carcinoma. While patients facing basal cell carcinoma have multiple choices available for […]